Hayfever Clinical Trial
Official title:
Assessment of Inflammatory Mediator and Cellular Changes Following Repeated Nasal Allergen Challenge in Subjects With Allergic Rhinitis Sensitive to Timothy Grass Pollen - a Validation Study
This is a non-drug, biomarker study to assess the utility of the model of repeated nasal allergen challenges in subjects with atopic rhinitis as a method of inducing an increased response to inhaled allergen, which will more closely resemble the responses seen during the hayfever season.
This is a non-drug, biomarker study to assess the utility of the model of repeated nasal allergen challenges in subjects with atopic rhinitis as a method of inducing an increased response to inhaled allergen, which will more closely resemble the responses seen during the hayfever season. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00232518 -
Randomised Controlled Clinical Trials of the Effect of Therapeutic Hookworm Infection in Allergic Rhinoconjunctivitis
|
N/A | |
| Completed |
NCT03755557 -
Demonstration of Equivalence and Early Onset of a Novel Anti-allergic Nasal Spray Compared to Marketed Nasal Spray
|
Phase 3 | |
| Withdrawn |
NCT00554736 -
Lactobacillus Acidophilus L92 on Markers of Allergic Inflammation by Nasal Provocation With Grass Pollen
|
Phase 3 | |
| Completed |
NCT00854360 -
Study to Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Patients 12 Years and Older With SAR
|
Phase 2 | |
| Completed |
NCT00150514 -
Effects of Sublingual Immunotherapy on Grasspollen Allergy
|
Phase 4 | |
| Completed |
NCT00115622 -
Study In Adults And Adolescents With Seasonal Allergic Rhinitis
|
Phase 3 |